|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-11-18
|
|
pubmed:abstractText |
Lipoproteins are a family of plasma nanoparticles responsible for the transportation of lipids throughout the body. High-density lipoprotein (HDL), the smallest of the lipoprotein family, measures 7-13 nm in diameter and consists of a cholesteryl ester and triglyceride core that is covered with a monolayer of phospholipids and apolipoproteins. We have developed an iron oxide core HDL nanoparticle (FeO-HDL), which has a lipid based fluorophore incorporated in the phospholipid layer. This nanoparticle provides contrast for optical imaging, magnetic resonance imaging (MRI) and transmission electron microscopy (TEM). Consequently, FeO-HDL can be visualized on the anatomical, cellular and sub-cellular level. In the current study we show that the biophysical features of FeO-HDL closely resemble those of native HDL and that FeO-HDL possess the ability to mimic HDL characteristics both in vitro as well as in vivo. We demonstrate that FeO-HDL can be applied to image HDL interactions and to investigate disease settings where HDL plays a key function. More generally, we have demonstrated a multimodal approach to study the behavior of biomaterials in vitro as well as in vivo. The approach allowed us to study nanoparticle dynamics in circulation, as well as nanoparticle targeting and uptake by tissues and cells of interest. Moreover, we were able to qualitatively assess nanoparticle excretion, critical for translating nanotechnologies to the clinic.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1878-5905
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
206-13
|
|
pubmed:dateRevised |
2011-4-19
|
|
pubmed:meshHeading |
pubmed-meshheading:20926130-Animals,
pubmed-meshheading:20926130-Aorta,
pubmed-meshheading:20926130-Apolipoproteins E,
pubmed-meshheading:20926130-Atherosclerosis,
pubmed-meshheading:20926130-Biological Transport,
pubmed-meshheading:20926130-Cell Survival,
pubmed-meshheading:20926130-Cholesterol,
pubmed-meshheading:20926130-Ferric Compounds,
pubmed-meshheading:20926130-Hep G2 Cells,
pubmed-meshheading:20926130-Hepatocytes,
pubmed-meshheading:20926130-Humans,
pubmed-meshheading:20926130-Injections, Intravenous,
pubmed-meshheading:20926130-Kupffer Cells,
pubmed-meshheading:20926130-Lipoproteins, HDL,
pubmed-meshheading:20926130-Macrophages,
pubmed-meshheading:20926130-Mice,
pubmed-meshheading:20926130-Mice, Knockout,
pubmed-meshheading:20926130-Microscopy, Confocal,
pubmed-meshheading:20926130-Nanoparticles
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis.
|
|
pubmed:affiliation |
Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, One Gustave, L. Levy Place, Box 1234, New York, NY 10029, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, N.I.H., Extramural
|
